Event time: 事件时间：
Published: 文章发布：
RBC Capital raises DXCM target to $105 from $90RBC Capital 上调目标价 德康医疗 (DXCM)：$90 → $105
On 2026-10-01, RBC Capital raised its DXCM price target to $105 from $90 (+16.7%).
RBC Capital 于 2026-10-01 将 DXCM 目标价上调至 $105，此前为 $90，变动幅度 +16.7%。
For information only. Not investment advice.内容仅供参考，不构成投资建议。